• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Live-attenuated auxotrophic mutant of Salmonella typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1

tetano

Editor, Senior Moderator
Future Microbiol. 2017 Jun 8. doi: 10.2217/fmb-2016-0190. [Epub ahead of print]
[h=1]Live-attenuated auxotrophic mutant of Salmonella typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1 influenza virus infection.[/h] Kamble NM[SUP]1[/SUP], Hyoung KJ[SUP]1[/SUP], Lee JH[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]AIM:[/h] To evaluate the efficacy of attenuated Salmonella typhimurium (JOL912) as a live bacterial vaccine vector.
[h=4]MATERIALS & METHODS:[/h] The JOL912 engineered to deliver HA1 protein from influenza A/Puerto Rico/8/1934 (H1N1; PR8) virus was coined as JOL1635 and further evaluated for immunogenicity and protective efficacy.
[h=4]RESULTS:[/h] The JOL1635 stably harbored the HA1 gene within pMMP65 plasmid with periplasmic expression and effective delivery of HA1 protein to RAW264.7 cells. The JOL1635 immunized chickens showed the significant increase in HA1-specific IgG, sIgA antibody, IFN-γ, IL-6 cytokine and cellular immune responses. The postoral challenge, the JOL1635-immunized chickens showed a faster clearance of PR8 virus cloacal shedding than the control group.
[h=4]CONCLUSION:[/h] Generated JOL1635 can establish specific immunogenicity and protection against the PR8 virus in chickens.


[h=4]KEYWORDS:[/h] LBV; Salmonella typhimurium; chicken; influenza; vaccine

PMID: 28594235 DOI: 10.2217/fmb-2016-0190
 
Back
Top Bottom